779 results on '"Tan, Wenjie"'
Search Results
152. Ferritin nanoparticle based SARS-CoV-2 RBD vaccine induces persistent antibody response and long-term memory in mice
153. Comparative viromes of Culicoides and mosquitoes reveal their consistency and diversity in viral profiles
154. Immunogenicity and Safety of a 3-Dose Regimen of a SARS-CoV-2 Inactivated Vaccine in Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
155. Strong Influence of Human Leukocyte Antigen (Hla)-Dp Gene Variants on Development of Persistent Chronic Hepatitis B Virus Carriers in The Han Chinese Population
156. Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection
157. Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2
158. NS1-based DNA vaccination confers mouse protective immunity against ZIKV challenge
159. A comparison of Remdesivir versus Au22Glutathione18 in COVID-19 golden hamsters: a better therapeutic outcome of gold compound
160. A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
161. Genetic tracing of HCoV-19 for the re-emerging outbreak of COVID-19 in Beijing, China
162. Scholarly Paper Recommendation via Related Path Analysis in Knowledge Graph
163. Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
164. Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
165. Increased Pathogenicity and Virulence of Middle East Respiratory Syndrome Coronavirus Clade B In Vitro and In Vivo
166. A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
167. One Hundred Days of Coronavirus Disease 2019 Prevention and Control in China
168. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
169. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
170. A non-competing pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
171. A Novel Protein Drug, Novaferon, as the Potential Antiviral Drug for COVID-19
172. Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro
173. Orthogonal genome-wide screenings in bat cells identify MTHFD1 as a target of broad antiviral therapy
174. Caspofungin and LTX-315 inhibit SARS-CoV-2 replication by targeting the nsp12 polymerase
175. Non-replicating Vaccinia Virus TianTan Strain (NTV) Translation Arrest of Viral Late Protein Synthesis Associated With Anti-viral Host Factor SAMD9
176. Detection of SARS-CoV-2 in Different Types of Clinical Specimens
177. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
178. Mutations, Recombination and Insertion in the Evolution of 2019-nCoV
179. Age‐related rhesus macaque models of COVID‐19
180. A distinct name is needed for the new coronavirus
181. A Novel Coronavirus from Patients with Pneumonia in China, 2019
182. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
183. Non-invasive bioluminescence imaging of HCoV-OC43 infection and therapy in the central nervous system of live mice
184. Hepatitis B virus precore protein augments genetic immunizations of the truncated hepatitis C virus core in BALB/c mice
185. Antitumor Activity of Chloroform Fraction of Scutellaria barbata and its Active Constituents
186. Safe delivery of therapeutic genes into specific chromosomal sites using engineered retroviral integrase
187. The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection
188. Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice
189. A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants.
190. Comparative viromes of Culicoides and mosquitoes reveal their consistency and diversity in viral profiles.
191. Rapid production of few layer graphene for energy storage via dry exfoliation of expansible graphite
192. Characterization of whole genomes from recently emerging Mpox cases in several regions of China, 2023
193. Unravelling the enhanced vaccine immunity by heterologous KCONVAC/Ad5-nCoV COVID-19 vaccination.
194. Development and Evaluation of a Universal and Supersensitive NS1-Based Luciferase Immunosorbent Assay to Detect Zika Virus-Specific IgG
195. Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats
196. High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses
197. Development and optimized pairing of mouse monoclonal antibodies for detecting hemagglutinin in novel H7 subtype influenza viruses
198. A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
199. Edge detection for optical synthetic apertures based on conditional generative adversarial networks
200. Humoral and cellular immunity against both ZIKV and poxvirus is elicited by a two-dose regimen using DNA and non-replicating vaccinia virus-based vaccine candidates
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.